BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 16157394)

  • 1. Behavioural consequences of withdrawal from three different administration schedules of amphetamine.
    Russig H; Murphy CA; Feldon J
    Behav Brain Res; 2005 Nov; 165(1):26-35. PubMed ID: 16157394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects on prepulse inhibition of withdrawal from two different repeated administration schedules of amphetamine.
    Peleg-Raibstein D; Sydekum E; Feldon J
    Int J Neuropsychopharmacol; 2006 Dec; 9(6):737-49. PubMed ID: 16448582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amphetamine withdrawal leads to behavioral sensitization and reduced HPA axis response following amphetamine challenge.
    Russig H; Pryce CR; Feldon J
    Brain Res; 2006 Apr; 1084(1):185-95. PubMed ID: 16563358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amphetamine sensitization in rats as an animal model of schizophrenia.
    Peleg-Raibstein D; Knuesel I; Feldon J
    Behav Brain Res; 2008 Aug; 191(2):190-201. PubMed ID: 18486243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentially altered mGluR1 and mGluR5 mRNA expression in rat caudate nucleus and nucleus accumbens in the development and expression of behavioral sensitization to repeated amphetamine administration.
    Mao L; Wang JQ
    Synapse; 2001 Sep; 41(3):230-40. PubMed ID: 11418936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prepulse inhibition during withdrawal from an escalating dosage schedule of amphetamine.
    Russig H; Murphy CA; Feldon J
    Psychopharmacology (Berl); 2003 Sep; 169(3-4):340-53. PubMed ID: 12428150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the long-term consequences of withdrawal from repeated amphetamine exposure in adolescence and adulthood on information processing and locomotor sensitization in mice.
    Richetto J; Feldon J; Riva MA; Meyer U
    Eur Neuropsychopharmacol; 2013 Feb; 23(2):160-70. PubMed ID: 22609316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amphetamine withdrawal does not produce a depressive-like state in rats as measured by three behavioral tests.
    Russig H; Pezze MA; Nanz-Bahr NI; Pryce CR; Feldon J; Murphy CA
    Behav Pharmacol; 2003 Feb; 14(1):1-18. PubMed ID: 12576877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An activity indicator of acute withdrawal depends on amphetamine dose in rats.
    White W; White IM
    Physiol Behav; 2006 Feb; 87(2):368-76. PubMed ID: 16364380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensorimotor gating effects produced by repeated dopamine agonists in a paradigm favoring environmental conditioning.
    Feifel D; Priebe K; Johnstone-Miller E; Morgan CJ
    Psychopharmacology (Berl); 2002 Jul; 162(2):138-46. PubMed ID: 12110991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A putative animal model of the "prodromal" state of schizophrenia.
    Tenn CC; Fletcher PJ; Kapur S
    Biol Psychiatry; 2005 Mar; 57(6):586-93. PubMed ID: 15780845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Withdrawal from continuous amphetamine administration abolishes latent inhibition but leaves prepulse inhibition intact.
    Peleg-Raibstein D; Sydekum E; Russig H; Feldon J
    Psychopharmacology (Berl); 2006 Apr; 185(2):226-39. PubMed ID: 16470402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Necessary role for ventral tegmental area adenylate cyclase and protein kinase A in induction of behavioral sensitization to intraventral tegmental area amphetamine.
    Tolliver BK; Ho LB; Fox LM; Berger SP
    J Pharmacol Exp Ther; 1999 Apr; 289(1):38-47. PubMed ID: 10086985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of short-term abstinence from escalating doses of D-amphetamine on drug and sucrose-evoked dopamine efflux in the rat nucleus accumbens.
    Vacca G; Ahn S; Phillips AG
    Neuropsychopharmacology; 2007 Apr; 32(4):932-9. PubMed ID: 16885936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of group II, but not group I, mGluRs in the rat nucleus accumbens inhibits the expression of conditioned hyperactivity in an amphetamine-associated environment.
    Kim WY; Vezina P; Kim JH
    Behav Brain Res; 2008 Aug; 191(1):62-6. PubMed ID: 18433894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed onset of prepulse inhibition deficits following kainic acid treatment on postnatal day 7 in rats.
    Howland JG; Hannesson DK; Phillips AG
    Eur J Neurosci; 2004 Nov; 20(10):2639-48. PubMed ID: 15548207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of amphetamine on serotoninergic and GABAergic expression of developing brain.
    Yin HS; Tan HW
    Neurotoxicol Teratol; 2007; 29(2):264-72. PubMed ID: 17137750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Latent inhibition, but not prepulse inhibition, is reduced during withdrawal from an escalating dosage schedule of amphetamine.
    Murphy CA; Fend M; Russig H; Feldon J
    Behav Neurosci; 2001 Dec; 115(6):1247-56. PubMed ID: 11770056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amphetamine and stress responses in developmentally lead-exposed rats.
    Virgolini MB; Volosin M; Fulginiti AS; Cancela LM
    Neurotoxicol Teratol; 2004; 26(2):291-303. PubMed ID: 15019963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of acute withdrawal during periodic administration of amphetamine in rats.
    White W; Feldon J; White IM
    Pharmacol Biochem Behav; 2004 Sep; 79(1):55-63. PubMed ID: 15388284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.